Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Orv Hetil ; 155(34): 1335-43, 2014 Aug 24.
Article in Hungarian | MEDLINE | ID: mdl-25131526

ABSTRACT

Cerebrovascular diseases are associated with a high incidence of psychiatric disorders. Depressive illness after stroke has been extensively investigated during the last three decades. Post-stroke depression is estimated to occur in 30-35% of the patients during the first year after stroke. Numerous studies have given information on its prevalence, pathogenesis, clinical course, treatment and prevention. Despite the high level of comorbidity, depressive symptoms appear to remain frequently unrecognized and untreated. This has a negative effect on the rehabilitation, quality of live, cognitive function and mortality of stroke patients.


Subject(s)
Cognition , Depression , Quality of Life , Stroke/psychology , Depression/diagnosis , Depression/epidemiology , Depression/etiology , Depression/physiopathology , Depression/prevention & control , Depression/therapy , Humans , Mass Screening , Prevalence , Risk Factors , Severity of Illness Index , Stroke/mortality , Stroke/physiopathology , Stroke Rehabilitation
2.
Atten Defic Hyperact Disord ; 5(1): 29-40, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23070786

ABSTRACT

Parental ADHD may be a significant barrier to a successful treatment for the child's ADHD. The objective of our randomized controlled trial was to evaluate whether the treatment for maternal ADHD improves the efficacy of a behavioural parent training for children's ADHD. Patient enrolment and a description of the full analysis set (FAS) of mother-child pairs with non-missing baseline data are presented. One hundred and forty-four mother-child pairs were randomized to two treatments for maternal ADHD: cognitive behavioural group psychotherapy plus open methylphenidate treatment or control treatment (supportive counselling). After 3 months of treatment for maternal ADHD, mother-child pairs participated in a behavioural parent-child training. Assessment for eligibility included standardized instruments. After pre-screening out of 444 mother-child pairs, 206 were evaluated for trial participation and 144 were randomized. The FAS was built up by 143 dyads (children: mean age 9.4 years, 73 % males; mothers: mean age: 38.3 years). Fifty-two per cent of the children and 66 % of the mothers had combined ADHD subtype. Current axis-I co-morbidity rates were 48 % in children and 31 % in mothers. Maternal axis-II co-morbidity was 20.1 %. Fifty-seven per cent of the mothers lived together with the father of the index-child, and 29 % were single mothers. Sixty-two per cent had part-time or full-time employment. There was a selection bias excluding mothers with lack of time and effort for participation and mothers affected by coexisting mental and physical illness. Nevertheless, for our trial we were able to collect a sample comparable to routine psychiatric outpatient settings (registration: CCT-ISRCTN73911400, funding: BMBF-01GV0605).


Subject(s)
Attention Deficit Disorder with Hyperactivity/drug therapy , Attention Deficit Disorder with Hyperactivity/therapy , Cognitive Behavioral Therapy , Methylphenidate/therapeutic use , Mothers/psychology , Patient Selection , Adult , Child , Clinical Protocols , Combined Modality Therapy , Female , Humans , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...